Lilly
Company Snapshot
Founded: 1876
Entity Type: Public
Employees: 50,000
Region: U.S.
Revenue: $65,179.0 Millions
Revenue Year: 2025
Segment: Biologics and insulin
Headquarter: Indiana, U.S.
Key Geographics: Europe, U.S., Japan, China
Corporate Address: Lilly Corporate Center, Indianapolis, Indiana 46285 U.S. Tel. +1- 317-276-2000 www.lilly.com
Company Overview
Lilly operates under one business segment, i.e. human pharmaceutical products across various therapeutic areas, including diabetes, obesity, and other cardiometabolic diseases, as well as oncology, immunology, and neuroscience. The company manufactures and distributes its products through the U.S., Puerto Rico, Europe, and Asia. Its products are available in over 105 countries.
Financial Highlights (FY 2025)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Company's Business Segments
- Cardiometabolic Health : Offers Mounjaro, Zepbound, Trulicity, Jardiance and others.
- Oncology : Offers Verzenio and others.
- Immunology : It offers Ebglyss, Olumiant, Omvoh and Taltz.
- Neuroscience : Offers Emgality and Kisunla.
Applications/End User Industries
- Diabetes Centers
- Diabetes Clinics
- Diabetes Management
- Oncologists
- Hematologists
- Biopharmaceutical
- Cancer Research and Development
- Rheumatologists
- Dermatologists
- Immunologists
- Autoimmune Diseases Clinics
- Psychiatrists
- Neuroscience Clinics
- Psychologists Centers
- Psychiatric Departments
- Urologists
- Cardiologists
- Infectious Disease Specialists
- Gastroenterologists
- Pulmonologists